 | • レポートコード：GIR201113973 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：サービス・ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、コンピュテーショナル創薬の世界市場を調査対象にし、コンピュテーショナル創薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（構造ベースドラッグデザイン（SBDD）、リガンドベースドラッグデザイン（LBDD）、シーケンスベースアプローチ）、用途別分析（腫瘍性疾患、神経疾患、免疫疾患、感染症、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：AMRI、BioDuro、Evotec、Charles River、AstraZeneca、Schrödinger、Aris Pharmaceuticals、GVK Biosciences、Bayers、BOC Sciences、ChemDiv、Pharmaron、RTI International、XRQTC ・企業別売上、市場シェア ・コンピュテーショナル創薬の地域別市場分析 ・コンピュテーショナル創薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・コンピュテーショナル創薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・コンピュテーショナル創薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・コンピュテーショナル創薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・コンピュテーショナル創薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・コンピュテーショナル創薬の種類別市場規模2015-2020：構造ベースドラッグデザイン（SBDD）、リガンドベースドラッグデザイン（LBDD）、シーケンスベースアプローチ ・コンピュテーショナル創薬の用途別市場規模2015-2020：腫瘍性疾患、神経疾患、免疫疾患、感染症、その他 ・コンピュテーショナル創薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Computational Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Computational Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of XX%% in the forecast period of 2020 to 2025 and will expected to reach USD XX million by 2025, from USD XX million in 2019.
Market segmentation
Computational Drug Discovery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Computational Drug Discovery market has been segmented into:
Structure-based Drug Design (SBDD)
Ligand-based Drug Design (LBDD)
Sequence-based Approaches
By Application, Computational Drug Discovery has been segmented into:
Oncological Disorders
Neurological Disorders
Immunological Disorders
Infectious Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Computational Drug Discovery market presented in the report. This section sheds light on the sales growth of different regional and country-level Computational Drug Discovery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Computational Drug Discovery market.
The report offers in-depth assessment of the growth and other aspects of the Computational Drug Discovery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Computational Drug Discovery Market Share Analysis
Computational Drug Discovery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Computational Drug Discovery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Computational Drug Discovery sales, revenue and market share for each player covered in this report.
The major players covered in Computational Drug Discovery are:
AMRI
BioDuro
Evotec
Charles River
AstraZeneca
Schrödinger
Aris Pharmaceuticals
GVK Biosciences
Bayers
BOC Sciences
ChemDiv
Pharmaron
RTI International
XRQTC
Among other players domestic and global, Computational Drug Discovery market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Computational Drug Discovery Market Overview
1.1 Product Overview and Scope of Computational Drug Discovery
1.2 Classification of Computational Drug Discovery by Type
1.2.1 Global Computational Drug Discovery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Computational Drug Discovery Revenue Market Share by Type in 2019
1.2.3 Structure-based Drug Design (SBDD)
1.2.4 Ligand-based Drug Design (LBDD)
1.2.5 Sequence-based Approaches
1.3 Global Computational Drug Discovery Market by Application
1.3.1 Overview: Global Computational Drug Discovery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Immunological Disorders
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Global Computational Drug Discovery Market by Regions
1.4.1 Global Computational Drug Discovery Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Computational Drug Discovery (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Computational Drug Discovery Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Computational Drug Discovery Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Computational Drug Discovery Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Computational Drug Discovery Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Computational Drug Discovery Status and Prospect (2015-2025)
2 Company Profiles
2.1 AMRI
2.1.1 AMRI Details
2.1.2 AMRI Major Business
2.1.3 AMRI SWOT Analysis
2.1.4 AMRI Product and Services
2.1.5 AMRI Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioDuro
2.2.1 BioDuro Details
2.2.2 BioDuro Major Business
2.2.3 BioDuro SWOT Analysis
2.2.4 BioDuro Product and Services
2.2.5 BioDuro Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.3 Evotec
2.3.1 Evotec Details
2.3.2 Evotec Major Business
2.3.3 Evotec SWOT Analysis
2.3.4 Evotec Product and Services
2.3.5 Evotec Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.4 Charles River
2.4.1 Charles River Details
2.4.2 Charles River Major Business
2.4.3 Charles River SWOT Analysis
2.4.4 Charles River Product and Services
2.4.5 Charles River Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.6 Schrödinger
2.6.1 Schrödinger Details
2.6.2 Schrödinger Major Business
2.6.3 Schrödinger Product and Services
2.6.4 Schrödinger Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aris Pharmaceuticals
2.7.1 Aris Pharmaceuticals Details
2.7.2 Aris Pharmaceuticals Major Business
2.7.3 Aris Pharmaceuticals Product and Services
2.7.4 Aris Pharmaceuticals Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.8 GVK Biosciences
2.8.1 GVK Biosciences Details
2.8.2 GVK Biosciences Major Business
2.8.3 GVK Biosciences Product and Services
2.8.4 GVK Biosciences Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayers
2.9.1 Bayers Details
2.9.2 Bayers Major Business
2.9.3 Bayers Product and Services
2.9.4 Bayers Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.10 BOC Sciences
2.10.1 BOC Sciences Details
2.10.2 BOC Sciences Major Business
2.10.3 BOC Sciences Product and Services
2.10.4 BOC Sciences Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.11 ChemDiv
2.11.1 ChemDiv Details
2.11.2 ChemDiv Major Business
2.11.3 ChemDiv Product and Services
2.11.4 ChemDiv Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pharmaron
2.12.1 Pharmaron Details
2.12.2 Pharmaron Major Business
2.12.3 Pharmaron Product and Services
2.12.4 Pharmaron Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.13 RTI International
2.13.1 RTI International Details
2.13.2 RTI International Major Business
2.13.3 RTI International Product and Services
2.13.4 RTI International Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.14 XRQTC
2.14.1 XRQTC Details
2.14.2 XRQTC Major Business
2.14.3 XRQTC Product and Services
2.14.4 XRQTC Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Computational Drug Discovery Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Computational Drug Discovery Players Market Share
3.2.2 Top 10 Computational Drug Discovery Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Computational Drug Discovery Revenue and Market Share by Regions
4.2 North America Computational Drug Discovery Revenue and Growth Rate (2015-2020)
4.3 Europe Computational Drug Discovery Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Computational Drug Discovery Revenue and Growth Rate (2015-2020)
4.5 South America Computational Drug Discovery Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Computational Drug Discovery Revenue and Growth Rate (2015-2020)
5 North America Computational Drug Discovery Revenue by Countries
5.1 North America Computational Drug Discovery Revenue by Countries (2015-2020)
5.2 USA Computational Drug Discovery Revenue and Growth Rate (2015-2020)
5.3 Canada Computational Drug Discovery Revenue and Growth Rate (2015-2020)
5.4 Mexico Computational Drug Discovery Revenue and Growth Rate (2015-2020)
6 Europe Computational Drug Discovery Revenue by Countries
6.1 Europe Computational Drug Discovery Revenue by Countries (2015-2020)
6.2 Germany Computational Drug Discovery Revenue and Growth Rate (2015-2020)
6.3 UK Computational Drug Discovery Revenue and Growth Rate (2015-2020)
6.4 France Computational Drug Discovery Revenue and Growth Rate (2015-2020)
6.5 Russia Computational Drug Discovery Revenue and Growth Rate (2015-2020)
6.6 Italy Computational Drug Discovery Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Computational Drug Discovery Revenue by Countries
7.1 Asia-Pacific Computational Drug Discovery Revenue by Countries (2015-2020)
7.2 China Computational Drug Discovery Revenue and Growth Rate (2015-2020)
7.3 Japan Computational Drug Discovery Revenue and Growth Rate (2015-2020)
7.4 Korea Computational Drug Discovery Revenue and Growth Rate (2015-2020)
7.5 India Computational Drug Discovery Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Computational Drug Discovery Revenue and Growth Rate (2015-2020)
8 South America Computational Drug Discovery Revenue by Countries
8.1 South America Computational Drug Discovery Revenue by Countries (2015-2020)
8.2 Brazil Computational Drug Discovery Revenue and Growth Rate (2015-2020)
8.3 Argentina Computational Drug Discovery Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Computational Drug Discovery by Countries
9.1 Middle East & Africa Computational Drug Discovery Revenue by Countries (2015-2020)
9.2 Saudi Arabia Computational Drug Discovery Revenue and Growth Rate (2015-2020)
9.3 UAE Computational Drug Discovery Revenue and Growth Rate (2015-2020)
9.4 Egypt Computational Drug Discovery Revenue and Growth Rate (2015-2020)
9.5 South Africa Computational Drug Discovery Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Computational Drug Discovery Revenue and Market Share by Type (2015-2020)
10.2 Global Computational Drug Discovery Market Forecast by Type (2019-2024)
10.3 Structure-based Drug Design (SBDD) Revenue Growth Rate (2015-2025)
10.4 Ligand-based Drug Design (LBDD) Revenue Growth Rate (2015-2025)
10.5 Sequence-based Approaches Revenue Growth Rate (2015-2025)
11 Global Computational Drug Discovery Market Segment by Application
11.1 Global Computational Drug Discovery Revenue Market Share by Application (2015-2020)
11.2 Computational Drug Discovery Market Forecast by Application (2019-2024)
11.3 Oncological Disorders Revenue Growth (2015-2020)
11.4 Neurological Disorders Revenue Growth (2015-2020)
11.5 Immunological Disorders Revenue Growth (2015-2020)
11.6 Infectious Diseases Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Computational Drug Discovery Market Size Forecast (2021-2025)
12.1 Global Computational Drug Discovery Market Size Forecast (2021-2025)
12.2 Global Computational Drug Discovery Market Forecast by Regions (2021-2025)
12.3 North America Computational Drug Discovery Revenue Market Forecast (2021-2025)
12.4 Europe Computational Drug Discovery Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Computational Drug Discovery Revenue Market Forecast (2021-2025)
12.6 South America Computational Drug Discovery Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Computational Drug Discovery Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Computational Drug Discovery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Computational Drug Discovery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Computational Drug Discovery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Computational Drug Discovery Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Computational Drug Discovery Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. AMRI Corporate Information, Location and Competitors
Table 7. AMRI Computational Drug Discovery Major Business
Table 8. AMRI Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 9. AMRI SWOT Analysis
Table 10. AMRI Computational Drug Discovery Product and Solutions
Table 11. AMRI Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. BioDuro Corporate Information, Location and Competitors
Table 13. BioDuro Computational Drug Discovery Major Business
Table 14. BioDuro Computational Drug Discovery Total Revenue (USD Million) (2018-2019)
Table 15. BioDuro SWOT Analysis
Table 16. BioDuro Computational Drug Discovery Product and Solutions
Table 17. BioDuro Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Evotec Corporate Information, Location and Competitors
Table 19. Evotec Computational Drug Discovery Major Business
Table 20. Evotec Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 21. Evotec SWOT Analysis
Table 22. Evotec Computational Drug Discovery Product and Solutions
Table 23. Evotec Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Charles River Corporate Information, Location and Competitors
Table 25. Charles River Computational Drug Discovery Major Business
Table 26. Charles River Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 27. Charles River SWOT Analysis
Table 28. Charles River Computational Drug Discovery Product and Solutions
Table 29. Charles River Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AstraZeneca Corporate Information, Location and Competitors
Table 31. AstraZeneca Computational Drug Discovery Major Business
Table 32. AstraZeneca Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 33. AstraZeneca SWOT Analysis
Table 34. AstraZeneca Computational Drug Discovery Product and Solutions
Table 35. AstraZeneca Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Schrödinger Corporate Information, Location and Competitors
Table 37. Schrödinger Computational Drug Discovery Major Business
Table 38. Schrödinger Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 39. Schrödinger SWOT Analysis
Table 40. Schrödinger Computational Drug Discovery Product and Solutions
Table 41. Schrödinger Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Aris Pharmaceuticals Corporate Information, Location and Competitors
Table 43. Aris Pharmaceuticals Computational Drug Discovery Major Business
Table 44. Aris Pharmaceuticals Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 45. Aris Pharmaceuticals SWOT Analysis
Table 46. Aris Pharmaceuticals Computational Drug Discovery Product and Solutions
Table 47. Aris Pharmaceuticals Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. GVK Biosciences Corporate Information, Location and Competitors
Table 49. GVK Biosciences Computational Drug Discovery Major Business
Table 50. GVK Biosciences Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 51. GVK Biosciences SWOT Analysis
Table 52. GVK Biosciences Computational Drug Discovery Product and Solutions
Table 53. GVK Biosciences Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bayers Corporate Information, Location and Competitors
Table 55. Bayers Computational Drug Discovery Major Business
Table 56. Bayers Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 57. Bayers SWOT Analysis
Table 58. Bayers Computational Drug Discovery Product and Solutions
Table 59. Bayers Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. BOC Sciences Corporate Information, Location and Competitors
Table 61. BOC Sciences Computational Drug Discovery Major Business
Table 62. BOC Sciences Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 63. BOC Sciences SWOT Analysis
Table 64. BOC Sciences Computational Drug Discovery Product and Solutions
Table 65. BOC Sciences Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. ChemDiv Corporate Information, Location and Competitors
Table 67. ChemDiv Computational Drug Discovery Major Business
Table 68. ChemDiv Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 69. ChemDiv SWOT Analysis
Table 70. ChemDiv Computational Drug Discovery Product and Solutions
Table 71. ChemDiv Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Pharmaron Corporate Information, Location and Competitors
Table 73. Pharmaron Computational Drug Discovery Major Business
Table 74. Pharmaron Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 75. Pharmaron SWOT Analysis
Table 76. Pharmaron Computational Drug Discovery Product and Solutions
Table 77. Pharmaron Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. RTI International Corporate Information, Location and Competitors
Table 79. RTI International Computational Drug Discovery Major Business
Table 80. RTI International Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 81. RTI International SWOT Analysis
Table 82. RTI International Computational Drug Discovery Product and Solutions
Table 83. RTI International Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. XRQTC Corporate Information, Location and Competitors
Table 85. XRQTC Computational Drug Discovery Major Business
Table 86. XRQTC Computational Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 87. XRQTC SWOT Analysis
Table 88. XRQTC Computational Drug Discovery Product and Solutions
Table 89. XRQTC Computational Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global Computational Drug Discovery Revenue (Million USD) by Players (2015-2020)
Table 91. Global Computational Drug Discovery Revenue Share by Players (2015-2020)
Table 92. Global Computational Drug Discovery Revenue (Million USD) by Regions (2015-2020)
Table 93. Global Computational Drug Discovery Revenue Market Share by Regions (2015-2020)
Table 94. North America Computational Drug Discovery Revenue by Countries (2015-2020)
Table 95. North America Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Table 96. Europe Computational Drug Discovery Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific Computational Drug Discovery Revenue (Million USD) by Countries (2015-2020)
Table 98. South America Computational Drug Discovery Revenue by Countries (2015-2020)
Table 99. South America Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa Computational Drug Discovery Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Table 102. Global Computational Drug Discovery Revenue (Million USD) by Type (2015-2020)
Table 103. Global Computational Drug Discovery Revenue Share by Type (2015-2020)
Table 104. Global Computational Drug Discovery Revenue Forecast by Type (2021-2025)
Table 105. Global Computational Drug Discovery Revenue by Application (2015-2020)
Table 106. Global Computational Drug Discovery Revenue Share by Application (2015-2020)
Table 107. Global Computational Drug Discovery Revenue Forecast by Application (2021-2025)
Table 108. Global Computational Drug Discovery Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Computational Drug Discovery Picture
Figure 2. Global Computational Drug Discovery Revenue Market Share by Type in 2019
Figure 3. Structure-based Drug Design (SBDD) Picture
Figure 4. Ligand-based Drug Design (LBDD) Picture
Figure 5. Sequence-based Approaches Picture
Figure 6. Computational Drug Discovery Revenue Market Share by Application in 2019
Figure 7. Oncological Disorders Picture
Figure 8. Neurological Disorders Picture
Figure 9. Immunological Disorders Picture
Figure 10. Infectious Diseases Picture
Figure 11. Others Picture
Figure 12. Global Computational Drug Discovery Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Computational Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Computational Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Computational Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Computational Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Computational Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Computational Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Computational Drug Discovery Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Computational Drug Discovery Revenue Market Share in 2019
Figure 21. Global Top 10 Players Computational Drug Discovery Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Computational Drug Discovery Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Computational Drug Discovery Revenue Market Share by Regions (2015-2020)
Figure 25. Global Computational Drug Discovery Revenue Market Share by Regions in 2018
Figure 26. North America Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 27. Europe Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 29. South America Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 31. North America Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 32. North America Computational Drug Discovery Revenue Market Share by Countries in 2019
Figure 33. USA Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 34. Canada Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 36. Europe Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Computational Drug Discovery Revenue Market Share by Countries in 2019
Figure 38. Germany Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 39. UK Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 40. France Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 41. Russia Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 42. Italy Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Computational Drug Discovery Revenue Market Share by Countries in 2019
Figure 45. China Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 46. Japan Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 47. Korea Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 48. India Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 50. South America Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 51. South America Computational Drug Discovery Revenue Market Share by Countries in 2019
Figure 52. Brazil Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Computational Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Computational Drug Discovery Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 57. UAE Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Computational Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 60. Global Computational Drug Discovery Revenue Share by Type (2015-2020)
Figure 61. Global Computational Drug Discovery Revenue Share by Type in 2019
Figure 62. Global Computational Drug Discovery Market Share Forecast by Type (2021-2025)
Figure 63. Global Structure-based Drug Design (SBDD) Revenue Growth Rate (2015-2020)
Figure 64. Global Ligand-based Drug Design (LBDD) Revenue Growth Rate (2015-2020)
Figure 65. Global Sequence-based Approaches Revenue Growth Rate (2015-2020)
Figure 66. Global Computational Drug Discovery Revenue Share by Application (2015-2020)
Figure 67. Global Computational Drug Discovery Revenue Share by Application in 2019
Figure 68. Global Computational Drug Discovery Market Share Forecast by Application (2021-2025)
Figure 69. Global Oncological Disorders Revenue Growth Rate (2015-2020)
Figure 70. Global Neurological Disorders Revenue Growth Rate (2015-2020)
Figure 71. Global Immunological Disorders Revenue Growth Rate (2015-2020)
Figure 72. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Computational Drug Discovery Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Computational Drug Discovery Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Computational Drug Discovery Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Computational Drug Discovery Revenue Market Forecast (2021-2025)
Figure 78. Europe Computational Drug Discovery Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Computational Drug Discovery Revenue Market Forecast (2021-2025)
Figure 80. South America Computational Drug Discovery Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Computational Drug Discovery Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
創薬におけるアウトソーシングの世界市場 2020年 Market Overview The global Outsourcing in Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Outsourcing in …- コンピュータ支援創薬（CADD ）サービスの世界市場 2020年 Market Overview The Computer-Aided Drug Discovery (CADD) Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 創薬アッセイの世界市場 2020年 Market Overview The global Drug Discovery Assays market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug Discovery Assays m…
- 生物製剤創薬の世界市場 2020年 Market Overview The global Biologics Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biologics Drug Disco…
- ラベルフリー創薬の世界市場 2020年 Market Overview The global Label-Free Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Label-Free Drug Dis…